Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancer-Reference-Cited by-同舟云学术

Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancer

Published:2016-08-22 Issue:41 Volume:7 Page:67071-67086
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Qian Jianchang¹,Chen Yaqing¹,Meng Tao²,Ma Lanping²,Meng Lanfang¹,Wang Xin²,Yu Ting²,Zask Arie³,Shen Jingkang²,Yu Ker¹

Affiliation:

1. Department of Pharmacology, Fudan University School of Pharmacy, Shanghai, China

2. Department of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

3. Department of Biological Sciences, Columbia University, New York, NY, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I dose escalation study and pilot efficacy analysis of LXI-15029, a novel mTOR dual inhibitor, in Chinese subjects with advanced malignant solid tumors;BMC Cancer;2023-12-06

2. Protective Autophagy Attenuates the Cytotoxicity of MTI-31 in Renal Cancer Cells by Activating the ERK Pathway;Applied Biochemistry and Biotechnology;2023-07-26

3. The role of liver kinase B1 in tumor progression through regulation of lipid metabolism;Clinical and Translational Oncology;2022-07-27

4. Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer;Cancers;2021-09-26

5. Regulation and metabolic functions of mTORC1 and mTORC2;Physiological Reviews;2021-07-01